Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Subclinical thyroid dysfunction and mortality: an estimate of relative and absolute excess all-cause mortality based on time-to-event data from cohort studies.

Haentjens P, Van Meerhaeghe A, Poppe K, Velkeniers B.

Eur J Endocrinol. 2008 Sep;159(3):329-41. doi: 10.1530/EJE-08-0110.

2.

Subclinical Thyroid Disease and Mortality in the Elderly: A Retrospective Cohort Study.

Grossman A, Weiss A, Koren-Morag N, Shimon I, Beloosesky Y, Meyerovitch J.

Am J Med. 2016 Apr;129(4):423-30. doi: 10.1016/j.amjmed.2015.11.027.

PMID:
26714213
3.

Duration of thyroid dysfunction correlates with all-cause mortality. the OPENTHYRO Register Cohort.

Laulund AS, Nybo M, Brix TH, Abrahamsen B, Jørgensen HL, Hegedüs L.

PLoS One. 2014 Oct 23;9(10):e110437. doi: 10.1371/journal.pone.0110437.

4.

Thyroid function, cardiovascular events, and mortality in diabetic hemodialysis patients.

Drechsler C, Schneider A, Gutjahr-Lengsfeld L, Kroiss M, Carrero JJ, Krane V, Allolio B, Wanner C, Fassnacht M.

Am J Kidney Dis. 2014 Jun;63(6):988-96. doi: 10.1053/j.ajkd.2013.10.009.

PMID:
24315768
5.

Thyroid function and mortality in patients treated for hyperthyroidism.

Franklyn JA, Sheppard MC, Maisonneuve P.

JAMA. 2005 Jul 6;294(1):71-80.

PMID:
15998893
6.

Endogenous subclinical thyroid disorders, physical and cognitive function, depression, and mortality in older individuals.

de Jongh RT, Lips P, van Schoor NM, Rijs KJ, Deeg DJ, Comijs HC, Kramer MH, Vandenbroucke JP, Dekkers OM.

Eur J Endocrinol. 2011 Oct;165(4):545-54. doi: 10.1530/EJE-11-0430.

7.

The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey.

Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge F, et al.

Clin Endocrinol (Oxf). 1995 Jul;43(1):55-68.

PMID:
7641412
8.

Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality.

Ochs N, Auer R, Bauer DC, Nanchen D, Gussekloo J, Cornuz J, Rodondi N.

Ann Intern Med. 2008 Jun 3;148(11):832-45.

PMID:
18490668
9.

Subclinical thyroid dysfunctions are independent risk factors for mortality in a 7.5-year follow-up: the Japanese-Brazilian thyroid study.

Sgarbi JA, Matsumura LK, Kasamatsu TS, Ferreira SR, Maciel RM.

Eur J Endocrinol. 2010 Mar;162(3):569-77. doi: 10.1530/EJE-09-0845.

10.

Higher free thyroxine levels are associated with all-cause mortality in euthyroid older men: the Health In Men Study.

Yeap BB, Alfonso H, Hankey GJ, Flicker L, Golledge J, Norman PE, Chubb SA.

Eur J Endocrinol. 2013 Sep 12;169(4):401-8. doi: 10.1530/EJE-13-0306.

11.

Subclinical and overt thyroid dysfunction and risk of all-cause mortality and cardiovascular events: a large population study.

Selmer C, Olesen JB, Hansen ML, von Kappelgaard LM, Madsen JC, Hansen PR, Pedersen OD, Faber J, Torp-Pedersen C, Gislason GH.

J Clin Endocrinol Metab. 2014 Jul;99(7):2372-82. doi: 10.1210/jc.2013-4184.

PMID:
24654753
12.

Prognostic impact of subclinical thyroid dysfunction in heart failure.

Frey A, Kroiss M, Berliner D, Seifert M, Allolio B, Güder G, Ertl G, Angermann CE, Störk S, Fassnacht M.

Int J Cardiol. 2013 Sep 20;168(1):300-5. doi: 10.1016/j.ijcard.2012.09.064.

PMID:
23041000
13.

Thyroid hormones as predictors of short- and long-term mortality in very old hospitalized patients.

De Alfieri W, Nisticò F, Borgogni T, Riello F, Cellai F, Mori C, Nante N, Di Bari M.

J Gerontol A Biol Sci Med Sci. 2013 Sep;68(9):1122-8. doi: 10.1093/gerona/glt012.

PMID:
23459207
14.

Subclinical hyperthyroidism and the risk of coronary heart disease and mortality.

Collet TH, Gussekloo J, Bauer DC, den Elzen WP, Cappola AR, Balmer P, Iervasi G, Åsvold BO, Sgarbi JA, Völzke H, Gencer B, Maciel RM, Molinaro S, Bremner A, Luben RN, Maisonneuve P, Cornuz J, Newman AB, Khaw KT, Westendorp RG, Franklyn JA, Vittinghoff E, Walsh JP, Rodondi N; Thyroid Studies Collaboration..

Arch Intern Med. 2012 May 28;172(10):799-809. doi: 10.1001/archinternmed.2012.402. Review.

15.

Thyroid status and functional and cognitive status at baseline and survival after 3 years of follow-up: the OCTABAIX study.

Formiga F, Ferrer A, Padros G, Contra A, Corbella X, Pujol R; Octabaix Study Group..

Eur J Endocrinol. 2013 Nov 22;170(1):69-75. doi: 10.1530/EJE-13-0722.

16.

Impact of thyroid dysfunction on erythropoietin dosage in hemodialysis patients.

Ng YY, Lin HD, Wu SC, Yang CY, Yang WC, Liou HH, Hu FH, Hou CC, Tseng SS, Ku NY, Hsiao NY, Wu WC, Tu HM, Lien TJ, Lee CC, Tsang KK, Cheng CS, Hu J, Lin RP.

Thyroid. 2013 May;23(5):552-61. doi: 10.1089/thy.2011.0495.

PMID:
23189968
17.

Subclinical thyroid dysfunction and the risk of heart failure in older persons at high cardiovascular risk.

Nanchen D, Gussekloo J, Westendorp RG, Stott DJ, Jukema JW, Trompet S, Ford I, Welsh P, Sattar N, Macfarlane PW, Mooijaart SP, Rodondi N, de Craen AJ; PROSPER Group..

J Clin Endocrinol Metab. 2012 Mar;97(3):852-61. doi: 10.1210/jc.2011-1978.

PMID:
22238391
18.

Comparison of mortality in hyperthyroidism during periods of treatment with thionamides and after radioiodine.

Boelaert K, Maisonneuve P, Torlinska B, Franklyn JA.

J Clin Endocrinol Metab. 2013 May;98(5):1869-82. doi: 10.1210/jc.2012-3459.

PMID:
23543662
19.

Relationship between subclinical thyroid dysfunction and the risk of fracture: a meta-analysis of prospective cohort studies.

Yan Z, Huang H, Li J, Wang J.

Osteoporos Int. 2016 Jan;27(1):115-25. doi: 10.1007/s00198-015-3221-z.

PMID:
26223189
20.

Maternal Thyroid Disease and Preterm Birth: Systematic Review and Meta-Analysis.

Sheehan PM, Nankervis A, Araujo Júnior E, Da Silva Costa F.

J Clin Endocrinol Metab. 2015 Nov;100(11):4325-31. doi: 10.1210/jc.2015-3074. Review.

PMID:
26383905
Items per page

Supplemental Content

Support Center